MACK News and Press, Merrimack Pharmaceuticals Inc. From 12/03/20

Palm Beach, FL – December 3, 2020 – Acute myeloid leukemia (AML) is a rare and heterogeneous blood cancer with a poor overall prognosis. It affects predominantly older adults with a median age at diagnosis of 66 years but also includes about 15% of children from birth to 19 ye...

Express (EXPR) -27% on Q3 earnings release.Splunk (SPLK) -21% on Q3 earnings release.Veritone (VERI) -20% on planned stock offering.Golar LNG (GLNG) -11% after launch offer of 11M shares in public offering.Merrimack Pharmaceuticals (MACK) -10%.AMC ...

Gainers: [[EVK]] +99.3%. [[WDR]] +47.9%. [[OMER]] +22.1%. [[ZS]] +12.1%. [[CRWD]] +11.8%.Losers: [[SPLK]] -18.8%. [[VERI]] -16.6%. [[GLNG]] -7.7%. [[MSP]] -5.4%. [[MACK]] 4.5%. For further details see: EVK, WDR, SPLK and VERI among after-hours movers

Gainers: NanoVibronix (NAOV) +99%.Merrimack Pharmaceuticals (MACK) +46%.Catabasis Pharmaceuticals (CATB) +44%.Tredegar (TG) +27%.Intec Pharma (NTEC) +27%.Kingsway Financial Services (KFS) +25%.Sequential Brands (SQBG) +23%.Sequans Communications (SQNS) +20%.Mmtec (MTC) +20%.Callon Petrol...

Thinly traded nano cap Merrimack Pharmaceuticals ([[MACK]] +42.2%) rallies on a whopping 309x surge in volume in apparent response to a corporate presentation yesterday by Ipsen S.A. ([[IPSEY]]).In the R&D section, management presented an update (slide 42) on Onivyde (irinotecan liposome ...

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its third quarter 2020 financial results for the period ended September 30, 2020. “We are pleased that both Ipsen Pharmaceuticals and Elevation Oncology c...

Gainers:  Midatech Pharma (NASDAQ: MTP ) +59% . More news on: Midatech Pharma plc, Mesoblast Limited, Sky Solar Holdings, Ltd., Stocks on the move, , Read more ...

Merrimack Pharmaceuticals (NASDAQ: MACK ) : Q2 GAAP EPS of -$0.09. More news on: Merrimack Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its second quarter 2020 financial results for the period ended June 30, 2020. “We are pleased by recent news releases from both Ipsen Pharmaceuticals and Elevat...

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its first quarter 2020 financial results for the period ended March 31, 2020. “We are pleased to report that we have significantly reduced our operating expen...